Maciej Kolodziej (Maciej Kołodziej)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Topics

Positron Emission Tomography

Neuroendocrine Tumors

Top Venues

International journal of molecular sciences

Nuclear medicine review. Central & Eastern Europe

This page only lists publications with an associated author ORCID identifier.

Publications

Marek Saracyn, Adam Daniel Durma, Barbara Bober, Arkadiusz Lubas, Maciej Kolodziej, Waldemar Kapusta, Beata Dmochowska, Grzegorz Kamiński
Renal Disturbances during and after Radioligand Therapy of Neuroendocrine Tumors-Extended Analysis of Potential Acute and Chronic Complications. International journal of molecular sciences 24 (8) (2023)
Adam Daniel Durma, Marek Saracyn, Maciej Kolodziej, Katarzyna Jóźwik-Plebanek, Beata Dmochowska, Adrianna Mróz, Wawrzyniec Żmudzki, Grzegorz Kamiński
Radioligand Therapy with [ 177 Lu]Lu-DOTA-TATE or [ 177 Lu]Lu-DOTA-TATE and [ 90 Y]Y-DOTA-TATE in Patients with Neuroendocrine Neoplasms of Unknown Locations, or Locations Other Than the Midgut and Pancreas as Primaries in a G1, G2 and G3 Grade. Pharmaceuticals (Basel, Switzerland) 16 (9) (2023)
Adam Daniel Durma, Marek Saracyn, Maciej Kolodziej, Katarzyna Jóźwik-Plebanek, Beata Dmochowska, Waldemar Kapusta, Wawrzyniec Żmudzki, Adrianna Mróz, Beata Kos-Kudła, Grzegorz Kamiński
Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [ 177 Lu]Lu-DOTA-TATE or [ 177 Lu]Lu-DOTA-TATE and [ 90 Y]Y-DOTA-TATE-A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm Center. Cancers 15 (22) (2023)
Marek Saracyn, Adam Daniel Durma, Barbara Bober, Arkadiusz Lubas, Maciej Kolodziej, Waldemar Kapusta, Beata Dmochowska, Grzegorz Kamiński
Renal Disturbances during and after Radioligand Therapy of Neuroendocrine Tumors-Extended Analysis of Potential Acute and Chronic Complications. International journal of molecular sciences 24 (8) (2023)
Marek Saracyn, Adam Daniel Durma, Barbara Bober, Arkadiusz Lubas, Maciej Kolodziej, Waldemar Kapusta, Beata Dmochowska, Grzegorz Kamiński
Renal Disturbances during and after Radioligand Therapy of Neuroendocrine Tumors-Extended Analysis of Potential Acute and Chronic Complications. International journal of molecular sciences 24 (8) (2023)
Maciej Kolodziej, Marek Saracyn, Arkadiusz Lubas, Mirosław Dziuk, Adam Daniel Durma, Jerzy Smoszna, Grzegorz Zelichowski, Stanisław Niemczyk, Grzegorz Kamiński
Usefulness of PET/CT with Carbon-11-Labeled Methionine in the Diagnosis of Tertiary Hyperparathyroidism. Nutrients 15 (1) (2022)
Maciej Kolodziej, Marek Saracyn, Arkadiusz Lubas, Mirosław Dziuk, Adam Daniel Durma, Jerzy Smoszna, Grzegorz Zelichowski, Stanisław Niemczyk, Grzegorz Kamiński
Usefulness of PET/CT with Carbon-11-Labeled Methionine in the Diagnosis of Tertiary Hyperparathyroidism. Nutrients 15 (1) (2022)
Marek Saracyn, Adam Daniel Durma, Barbara Bober, Maciej Kolodziej, Arkadiusz Lubas, Waldemar Kapusta, Stanisław Niemczyk, Grzegorz Kamiński
Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms. Nutrients 15 (1) (2022)
Marek Saracyn, Adam Daniel Durma, Barbara Bober, Maciej Kolodziej, Arkadiusz Lubas, Waldemar Kapusta, Stanisław Niemczyk, Grzegorz Kamiński
Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms. Nutrients 15 (1) (2022)
Marek Saracyn, Adam Daniel Durma, Barbara Bober, Maciej Kolodziej, Arkadiusz Lubas, Waldemar Kapusta, Stanisław Niemczyk, Grzegorz Kamiński
Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms. Nutrients 15 (1) (2022)
Maciej Kolodziej, Marek Saracyn, Arkadiusz Lubas, Mirosław Dziuk, Adam Daniel Durma, Jerzy Smoszna, Grzegorz Zelichowski, Stanisław Niemczyk, Grzegorz Kamiński
Usefulness of PET/CT with Carbon-11-Labeled Methionine in the Diagnosis of Tertiary Hyperparathyroidism. Nutrients 15 (1) (2022)
Maciej Kolodziej, Marek Saracyn, Arkadiusz Lubas, Dorota Brodowska-Kania, Andrzej Mazurek, Miroslaw Dziuk, Jolanta Dymus, Grzegorz Kamiński
Evaluation of the usefulness of positron emission tomography with [18F]fluorodeoxylglucose performed to detect non-radioiodine avid recurrence and/or metastasis of differentiated thyroid cancer - a preliminary study. Nuclear medicine review. Central & Eastern Europe 24 (2) (2021)
Katarzyna Kuśnierz, Paweł Gut, Dariusz Pawlak, Maciej Kolodziej, Leszek Królicki, Beata Kos-Kudla, Marek Ruchala, Grzegorz Kamiński, Jolanta Kunikowska
The Safety and Efficacy of the Repeated PRRT with [90Y]Y/[177Lu]Lu-DOTATATE in Patients with NET. International journal of endocrinology 2021 (2021)
Katarzyna Kuśnierz, Maciej Kolodziej, Paweł Gut, Leszek Królicki, Beata Kos-Kudla, Grzegorz Kamiński, Marek Ruchala, Dariusz Pawlak, Jolanta Kunikowska
Effect of peptide receptor radionuclide therapy (PRRT) with tandem isotopes - [90Y]Y/[177Lu]Lu-DOTATATE in patients with disseminated neuroendocrine tumours depending on [18F]FDG PET/CT qualification in Polish multicentre experience - do we need [18F]FDG PET/CT for qualification to PRRT? Endokrynologia Polska 71 (3) (2020)